<DOC>
	<DOCNO>NCT00035126</DOCNO>
	<brief_summary>This study examine whether investigational drug EPO906 , give intravenous infusion ( IV directly vein ) , effective shrinking tumor prevent growth cell cause breast cancer .</brief_summary>
	<brief_title>EPO906 Therapy Patients With Advanced Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<mesh_term>Epothilone B</mesh_term>
	<criteria>The following patient may eligible study : Histologically cytologically document evidence disease least one measurable lesion ; Life expectancy great three ( 3 ) month ; Patients one prior therapy metastatic disease ; Patients receive prior treatment hormonal agent prior treatment regimen radiotherapy addition one previous chemotherapy regimen eligible ; Patients prior therapy metastatic disease , receive taxane anthracycline ( single combination therapy ) adjuvant treatment , eligible . For patient previous radiation therapy target lesion ( ) , lesion ( ) must since demonstrate progression . The following patient eligible study : Boneonly disease ; Symptomatic pleural effusion ; Symptomatic CNS metastases leptomeningeal involvement ; Any peripheral neuropathy unresolved diarrhea great Grade 1 ; Severe cardiac insufficiency ; Patients take Coumadin warfarincontaining agent exception low dose Coumadin ( 1 mg less ) maintenance indwell line port ; History another malignancy within 5 year prior study entry except curatively treat nonmelanoma ckin cancer cervical cancer situ ; Active suspect acute chronic uncontrolled infection include abcesses fistulae ; HIV+ patient ; Pregnant lactating female ; Patients radiation , chemotherapy , hormonal therapy within last four ( 4 ) week exclude palliative radiotherapy isolate peripheral bone metastasis use marker efficacy ; Patients take Herceptin le three ( 3 ) week prior study start .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>breast</keyword>
	<keyword>cancer</keyword>
	<keyword>tumor</keyword>
	<keyword>tumour</keyword>
	<keyword>intravenous</keyword>
	<keyword>epothilone</keyword>
	<keyword>taxane</keyword>
	<keyword>anthracycline</keyword>
</DOC>